Why is Family Care falling/rising?
2025-11-07 22:03:54As of 07-Nov, Family Care Hospitals Ltd is experiencing a decline in its stock price, currently at 3.86, which reflects a decrease of 0.18 or 4.46%. The stock has been underperforming significantly, having lost 12.67% over the last nine consecutive days. It is trading below all key moving averages, indicating a bearish trend. Additionally, the stock's performance over various periods shows substantial underperformance compared to the benchmark, with a year-to-date decline of 42.04% against a 6.50% increase in the Sensex. Notably, there is a decrease in investor participation, as evidenced by a 23.57% drop in delivery volume compared to the five-day average, contributing to the stock's downward momentum. In the broader market context, Family Care's short-term performance is starkly contrasted with the Sensex, which has only declined by 0.86% over the past week while Family Care has fallen by 8.96%. This sig...
Read MoreWhy is Family Care falling/rising?
2025-11-04 21:56:00As of 04-Nov, Family Care Hospitals Ltd's stock price is currently at 4.14, reflecting a slight increase of 0.01 or 0.24%. The stock has shown a trend reversal, gaining after six consecutive days of decline. Despite this recent uptick, it is still trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 53.29% compared to the 5-day average. However, the stock has significantly underperformed over various periods, with a year-to-date decline of 37.84% and a one-year drop of 44.20%. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Family Care's short-term performance over the past week shows a decline of 3.72%, which contrasts with the Sensex's decline of only 1.38%. This i...
Read MoreIs Family Care overvalued or undervalued?
2025-10-30 08:06:25As of 29 October 2025, Family Care's valuation grade has moved from fair to risky, indicating a significant deterioration in its financial standing. The company is currently deemed overvalued, with a PE ratio of -3.62, an EV to EBITDA of -3.48, and a ROE of -47.73%. These figures suggest severe profitability issues, particularly when compared to its peers. For instance, Max Healthcare has a PE ratio of 96.03 and an EV to EBITDA of 59.47, while Apollo Hospitals shows a PE of 71.83 and an EV to EBITDA of 36.92, both indicating a stark contrast in financial health. The company’s performance has been notably poor, with a year-to-date return of -35.44%, significantly underperforming the Sensex, which has returned 8.78% in the same period. Given the substantial negative ratios and the company's poor performance relative to its peers, Family Care is clearly overvalued in the current market context....
Read MoreHow has been the historical performance of Family Care?
2025-10-29 22:42:29Answer: The historical performance of Family Care has shown significant fluctuations over the years, particularly in net sales and profitability. Breakdown: Family Care's net sales peaked at 47.30 Cr in March 2023 but dramatically fell to 7.90 Cr by March 2025. This decline in sales is reflected in the total operating income, which also decreased from 40.01 Cr in March 2024 to 7.90 Cr in March 2025. The company's total expenditure, which was 33.26 Cr in March 2024, turned negative at -20.51 Cr in March 2025, indicating a drastic change in operational efficiency. Operating profit, which had been positive in previous years, saw a significant rise to 31.56 Cr in March 2025, largely due to the negative expenditure. However, the profit before tax plummeted to -44.47 Cr in March 2025, following an exceptional item of -74.62 Cr. Consequently, profit after tax also fell to -44.15 Cr. The company's total assets de...
Read MoreAre Family Care latest results good or bad?
2025-10-29 19:18:05Family Care Hospitals has reported alarming financial results for the second quarter of FY26, highlighting significant operational distress. The company's revenue has dramatically declined to ₹0.07 crores, representing a staggering 98.20% decrease year-on-year from ₹3.88 crores in Q2 FY25. This decline indicates a near-total collapse of its revenue-generating operations, raising serious concerns about its business viability. The net profit for the quarter was a loss of ₹4.61 crores, worsening from a loss of ₹0.70 crores in the previous quarter. The operating margin stood at a deeply negative -6,271.43%, reflecting a severe breakdown in the business model. The profit and loss statement reveals that the company's operational performance has deteriorated significantly, with the operating profit before depreciation, interest, and tax (PBDIT) at negative ₹4.39 crores. In terms of balance sheet health, sharehol...
Read More
Family Care Hospitals Q2 FY26: Operational Crisis Deepens as Losses Mount
2025-10-29 09:01:32Family Care Hospitals Ltd., a micro-cap healthcare services company with a market capitalisation of ₹23.17 crores, reported a devastating second quarter for FY2026, posting a net loss of ₹4.61 crores on revenues of just ₹0.07 crores. The results represent a catastrophic deterioration from the previous quarter's loss of ₹0.70 crores, marking a sequential decline of 558.57%. The stock has responded to the company's ongoing struggles by declining 40.42% over the past year, significantly underperforming both the Sensex and its healthcare services sector peers.
Read MoreHow has been the historical performance of Family Care?
2025-10-28 22:55:27Answer: The historical performance of Family Care shows significant fluctuations over the years, particularly in net sales and profitability. Breakdown: Family Care's net sales peaked at 47.30 Cr in March 2023 but dropped sharply to 7.90 Cr by March 2025. The total operating income followed a similar trend, decreasing from 47.30 Cr in March 2023 to 7.90 Cr in March 2025. The company experienced a notable increase in operating profit (PBDIT) from 1.49 Cr in March 2019 to 31.56 Cr in March 2025, although this was accompanied by a drastic decline in profit before tax, which fell from 8.13 Cr in March 2024 to -44.47 Cr in March 2025. Consequently, profit after tax also turned negative, dropping from 12.55 Cr in March 2024 to -44.15 Cr in March 2025. The company's total assets decreased from 74.58 Cr in March 2023 to 46.09 Cr in March 2025, while total liabilities also fell from 69.96 Cr to 46.09 Cr in the same...
Read MoreIs Family Care overvalued or undervalued?
2025-10-28 08:04:35As of 27 October 2025, the valuation grade for Family Care has moved from expensive to fair. Based on the analysis, the company appears to be undervalued. Key ratios include a PE Ratio of 0.80, an EV to EBITDA of 0.97, and an impressive ROE of 219.63%. When compared to peers, Family Care's valuation stands out as more reasonable, particularly against Max Healthcare, which has a PE of 95.77, and Apollo Hospitals, with a PE of 71.65. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 34.08% compared to the Sensex's gain of 8.50%, the underlying financial metrics suggest that Family Care offers a compelling investment opportunity at its current price of 4.39....
Read MoreIs Family Care overvalued or undervalued?
2025-10-27 08:04:04As of 24 October 2025, the valuation grade for Family Care has moved from fair to expensive. Based on the analysis, the company is currently overvalued. Key ratios indicate this, with a PE Ratio of 0.82, an EV to EBITDA of 0.98, and an ROE of 219.63%. In comparison to its peers, Family Care's valuation metrics are significantly lower than those of Max Healthcare, which has a PE of 95.69, and Apollo Hospitals, with a PE of 71.66. The stark contrast in valuation suggests that Family Care is not only overvalued but also underperforming relative to its peers. Additionally, the company's stock has underperformed against the Sensex, with a YTD return of -32.88% compared to the Sensex's 7.77%, reinforcing the overvaluation narrative....
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
30-Oct-2025 | Source : BSEEclosed herewith publication of Newspaper for financial results of September Quarter 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
28-Oct-2025 | Source : BSEIntimation of Resignation of Chief Financial Officer Mr. Amit Satishchand Tyagi w.e.f. 28th October 2025
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Dated 28Th October 2025
28-Oct-2025 | Source : BSEEnclosed herewith Board Meeting outcomes dated 28th October 2025
Corporate Actions
No Upcoming Board Meetings
No Splits history available
No Bonus history available
Family Care Hospitals Ltd has announced 127:100 rights issue, ex-date: 03 Jan 23






